Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects

Nina E Hasselberg1, Thor Edvardsen, Helle Petri

  • 1Dept of Cardiology and Center for Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Insights

In Lamin A/C mutation carriers, a prolonged PR-interval predicts ventricular arrhythmias (VA). Septal fibrosis is linked to impaired heart function and VA, suggesting a mechanism for cardiac issues.

Area of Science:

  • Cardiology
  • Genetics
  • Cardiac Electrophysiology

Background:

  • Lamin A/C gene mutations are associated with various cardiac abnormalities, including arrhythmias and cardiomyopathy.
  • Understanding the predictors and mechanisms of ventricular arrhythmias (VA) in these patients is crucial for risk stratification and management.

Purpose of the Study:

  • To identify predictors of ventricular arrhythmias (VA) in individuals with Lamin A/C gene mutations.
  • To elucidate the underlying mechanisms of VA in this patient cohort.

Main Methods:

  • Retrospective analysis of 41 subjects with Lamin A/C mutations.
  • Assessment of PR-interval, occurrence of VA, left ventricular (LV) function (ejection fraction, strain) via echocardiography.
  • Cardiac magnetic resonance imaging (MRI) to evaluate myocardial fibrosis in a subset of patients.

Main Results:

  • Ventricular arrhythmias (VA) were present in 51% of subjects.
  • A prolonged PR-interval was the strongest predictor of VA (P < 0.001).
  • Reduced myocardial function in the interventricular septum correlated with prolonged PR-interval; septal fibrosis was exclusively found in patients with VA and associated with longer PR-intervals.

Conclusions:

  • Prolonged PR-interval is a key predictor of VA in Lamin A/C mutation-positive subjects.
  • Electrical, mechanical, and structural cardiac properties are interconnected in these patients.
  • Localized septal fibrosis appears to be a significant mechanism contributing to impaired septal function, atrioventricular block, and VA.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...